… lung microbiome (the entire community of microorganisms that inhabit the lower respiratory
tract) contributes centrally to both health and disease, particularly obstructive lung disease.1 …

… proven coronary artery disease in advanced lung disease is not well … artery disease
complicating advanced lung disease and to describe the frequency of occult coronary artery disease …

… Background: The clinical utility of bronchoalveolar lavage fluid (BAL) cell analysis for the
diagnosis and management of patients with interstitial lung disease (ILD) has been a subject of …

… , 7 and no known current lung disease or unstable cardiovascular disease) or current or …
pack-years, regardless of whether they had a clinical diagnosis of obstructive lung disease. …

… patient who actually proves to have diffuse cystic lung disease as revealed on HRCT. The
finding of diffuse cystic lung disease facilitates the diagnostic process because this radiologic …

… physiologic improvement occurs in only a minority of patients, and neither smoking cessation
nor immunosuppressive therapy is regularly associated with clinically significant benefit. …

… Our results show a clinically significant improvement in both functional status (as measured
by 6MWT distance) and dyspnea (as measured by Borg score and, in a subset of patients, …

… disease, or as a pulmonologist needing to determine the type, significance, and management
of lung disease… which may not be clinically significant. Of 36 patients with early rheumatoid …

… lung disease, and chronic obstructive pulmonary disease. This review will examine the current
clinical … 25(OH)D had a clinically significant decline in their lung function [FVC, P = 0.015; …

… with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype.
Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, …